Department of Surgery, Amsterdam Gastroenterology and Metabolism, Amsterdam Infection & Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Department of Plastic, Reconstructive & Hand Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Ann Surg. 2020 Jul;272(1):81-91. doi: 10.1097/SLA.0000000000003644.
The aim of this study was to evaluate the efficacy of iNPWT for the prevention of postoperative wound complications such as SSI.
The 2016 WHO recommendation on the use of iNPWT for the prevention of SSI is based on low-level evidence, and many trials have been published since. Preclinical evidence suggests that iNPWT may also prevent wound dehiscence, skin necrosis, seroma, and hematoma.
PubMed, EMBASE, CINAHL, and CENTRAL were searched for randomized and nonrandomized studies that compared iNPWT with control dressings. The evidence was assessed using the Cochrane Risk of Bias Tool, the Newcastle-Ottawa scale, and GRADE. Meta-analyses were performed using random-effects models.
High level evidence indicated that iNPWT reduced SSI [28 RCTs, n = 4398, relative risk (RR) 0.61, 95% confidence interval [CI]: 0.49-0.76, P < 0.0001, I = 27%] with a number needed to treat of 19. Low level evidence indicated that iNPWT reduced wound dehiscence (16 RCTs, n = 3058, RR 0.78, 95% CI: 0.64-0.94). Very low-level evidence indicated that iNPWT also reduced skin necrosis (RR 0.49, 95% CI: 0.33-0.74), seroma (RR 0.43, 95% CI: 0.32-0.59), and length of stay (pooled mean difference -2.01, 95% CI: -2.99 to 1.14).
High-level evidence indicates that incisional iNPWT reduces the risk of SSI with limited heterogeneity. Low to very low-level evidence indicates that iNPWT also reduces the risk of wound dehiscence, skin necrosis, and seroma.
本研究旨在评估 iNPWT 预防术后伤口并发症(如 SSI)的疗效。
2016 年世卫组织关于使用 iNPWT 预防 SSI 的建议基于低水平证据,此后已有许多试验发表。临床前证据表明,iNPWT 还可能预防伤口裂开、皮肤坏死、血清肿和血肿。
检索 PubMed、EMBASE、CINAHL 和 CENTRAL 中比较 iNPWT 与对照敷料的随机和非随机研究。使用 Cochrane 偏倚风险工具、纽卡斯尔-渥太华量表和 GRADE 评估证据。使用随机效应模型进行荟萃分析。
高水平证据表明,iNPWT 降低了 SSI [28 项 RCT,n = 4398,相对风险(RR)0.61,95%置信区间(CI):0.49-0.76,P < 0.0001,I = 27%],治疗需要数为 19。低水平证据表明,iNPWT 降低了伤口裂开(16 项 RCT,n = 3058,RR 0.78,95%CI:0.64-0.94)。极低水平证据表明,iNPWT 还降低了皮肤坏死(RR 0.49,95%CI:0.33-0.74)、血清肿(RR 0.43,95%CI:0.32-0.59)和住院时间(平均差值 -2.01,95%CI:-2.99 至 1.14)。
高水平证据表明,切口 iNPWT 可降低 SSI 风险,异质性有限。低至极低水平证据表明,iNPWT 还降低了伤口裂开、皮肤坏死和血清肿的风险。